Ekso Non Currrent Assets Other from 2010 to 2024

EKSO Stock  USD 0.69  0.01  1.43%   
Ekso Bionics Non Currrent Assets Other yearly trend continues to be very stable with very little volatility. Non Currrent Assets Other are likely to grow to about 504.2 K this year. Non Currrent Assets Other is assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents. View All Fundamentals
 
Non Currrent Assets Other  
First Reported
2014-03-31
Previous Quarter
435 K
Current Value
531 K
Quarterly Volatility
770.6 K
 
Yuan Drop
 
Covid
Check Ekso Bionics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ekso Bionics' main balance sheet or income statement drivers, such as Interest Expense of 271.3 K, Selling General Administrative of 8.7 M or Other Operating Expenses of 28.5 M, as well as many indicators such as Price To Sales Ratio of 1.8, Dividend Yield of 0.11 or PTB Ratio of 2.61. Ekso financial statements analysis is a perfect complement when working with Ekso Bionics Valuation or Volatility modules.
  
Check out the analysis of Ekso Bionics Correlation against competitors.

Latest Ekso Bionics' Non Currrent Assets Other Growth Pattern

Below is the plot of the Non Currrent Assets Other of Ekso Bionics Holdings over the last few years. It is assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents. Ekso Bionics' Non Currrent Assets Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ekso Bionics' overall financial position and show how it may be relating to other accounts over time.
Non Currrent Assets Other10 Years Trend
Slightly volatile
   Non Currrent Assets Other   
       Timeline  

Ekso Non Currrent Assets Other Regression Statistics

Arithmetic Mean1,006,349
Geometric Mean524,744
Coefficient Of Variation98.27
Mean Deviation922,787
Median392,000
Standard Deviation988,976
Sample Variance978.1B
Range2.5M
R-Value(0.77)
Mean Square Error421.8B
R-Squared0.60
Significance0.0007
Slope(171,237)
Total Sum of Squares13.7T

Ekso Non Currrent Assets Other History

2024504.2 K
2023392 K
2022231 K
2021164 K
2020320 K
2019178 K
2018134 K

About Ekso Bionics Financial Statements

Ekso Bionics investors utilize fundamental indicators, such as Non Currrent Assets Other, to predict how Ekso Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Non Currrent Assets Other392 K504.2 K

Pair Trading with Ekso Bionics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ekso Bionics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ekso Bionics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Ekso Stock

  0.63CI Cigna CorpPairCorr

Moving against Ekso Stock

  0.92ELMD ElectromedPairCorr
  0.89MD Mednax IncPairCorr
  0.89VREX Varex Imaging CorpPairCorr
  0.85OM Outset MedicalPairCorr
  0.83ECOR Electrocore LLCPairCorr
The ability to find closely correlated positions to Ekso Bionics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ekso Bionics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ekso Bionics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ekso Bionics Holdings to buy it.
The correlation of Ekso Bionics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ekso Bionics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ekso Bionics Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ekso Bionics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Ekso Bionics Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ekso Bionics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ekso Bionics Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ekso Bionics Holdings Stock:
Check out the analysis of Ekso Bionics Correlation against competitors.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ekso Bionics. If investors know Ekso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ekso Bionics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.64)
Revenue Per Share
1.004
Quarterly Revenue Growth
(0.10)
Return On Assets
(0.24)
Return On Equity
(0.74)
The market value of Ekso Bionics Holdings is measured differently than its book value, which is the value of Ekso that is recorded on the company's balance sheet. Investors also form their own opinion of Ekso Bionics' value that differs from its market value or its book value, called intrinsic value, which is Ekso Bionics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ekso Bionics' market value can be influenced by many factors that don't directly affect Ekso Bionics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ekso Bionics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ekso Bionics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ekso Bionics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.